Pasithea Therapeutics (KTTA) Accumulated Depreciation & Amortization (2022 - 2024)
Historic Accumulated Depreciation & Amortization for Pasithea Therapeutics (KTTA) over the last 3 years, with Q3 2024 value amounting to $5000.0.
- Pasithea Therapeutics' Accumulated Depreciation & Amortization fell 7336.46% to $5000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $5000.0, marking a year-over-year decrease of 7336.46%. This contributed to the annual value of $23488.0 for FY2023, which is 55996.07% up from last year.
- As of Q3 2024, Pasithea Therapeutics' Accumulated Depreciation & Amortization stood at $5000.0, which was down 7336.46% from $32920.0 recorded in Q2 2024.
- In the past 5 years, Pasithea Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $32920.0 in Q2 2024 and a low of $3559.0 during Q4 2022
- Over the past 3 years, Pasithea Therapeutics' median Accumulated Depreciation & Amortization value was $21130.0 (recorded in 2023), while the average stood at $18657.3.
- Per our database at Business Quant, Pasithea Therapeutics' Accumulated Depreciation & Amortization soared by 55996.07% in 2023 and then tumbled by 7336.46% in 2024.
- Over the past 3 years, Pasithea Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $3559.0 in 2022, then soared by 559.96% to $23488.0 in 2023, then tumbled by 78.71% to $5000.0 in 2024.
- Its Accumulated Depreciation & Amortization stands at $5000.0 for Q3 2024, versus $32920.0 for Q2 2024 and $28205.0 for Q1 2024.